価格表

在庫・価格 : 2024年05月18日 10時13分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
VEGF-C, Human, Recombinant
データシート
752-VC-025 RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥89,000
(未発注)
追加

在庫・価格 : 2024年05月18日 10時13分 現在

VEGF-C, Human, Recombinant

  • 商品コード:752-VC-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥89,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Al-Mowallad AF et al. Quantification of vascular endothelial growth factor-C. J. Immunol. Methods 2004 Jun;289(1-2):239-40
Al-Mowallad AF et al
2004/01/01
Application: ELISA Standard PubMed
2 Liersch R et al. Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood 2006 Feb;107(3):1214-6
Liersch R et al
2006/01/01
Sample Type: Whole Cells PubMed
3 Hamaguchi I et al. Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival. Blood 2006 Feb;107(3):1207-13
Hamaguchi I et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
4 Shin JW et al. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell 2006 Feb;17(2):576-84
Shin JW et al
2006/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
5 Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
Le Bras B et al
2006/01/01
Species: Mouse, Xenopus, Application: Bioassay, Whole Cells PubMed
6 Zeng Y et al. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res. 2006 Oct;66(19):9566-75
Zeng Y et al
2006/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
7 Goldman J et al. Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am. J. Physiol. Heart Circ. Physiol. 2007 May;292(5):H2176-83
Goldman J et al
2007/01/01
Species: Mouse, Application: In Vivo PubMed
8 Huber S et al. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int. 2007 Apr;71(8):771-7
Huber S et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
9 Taniguchi K et al. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol. Cell. Biol. 2007 Jun;27(12):4541-50
Taniguchi K et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
10 Kilic N et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007 Dec;110(13):4223-33
Kilic N et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
11 Uzarski J et al. The resolution of lymphedema by interstitial flow in the mouse tail skin. Am. J. Physiol. Heart Circ. Physiol. 2008 Mar;294(3):H1326-34
Uzarski J et al
2008/01/01
Species: Mouse, Application: Bioassay, In Vivo PubMed
12 Shin JW et al. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood 2008 Sep;112(6):2318-26
Shin JW et al
2008/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
13 Kajiya K et al. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J. Invest. Dermatol. 2009 May;129(5):1292-8
Kajiya K et al
2009/01/01
Application: In Vivo PubMed
14 Kodama M et al. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin. Cancer Res. 2008 Nov;14(22):7205-14
Kodama M et al
2008/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
15 Issa A et al. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 2009 Jan;69(1):349-57
Issa A et al
2009/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
16 Pan MR et al. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. J. Cell. Sci. 2009 Sep;122(Pt 18):3358-64
Pan MR et al
2009/01/01
Application: Media Supplement, Sample Type: Whole Cells PubMed
17 Chien MH et al. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis 2009 Dec;30(12):2005-13
Chien MH et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
18 Heishi T et al. Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am. J. Pathol. 2010 Apr;176(4):1950-8
Heishi T et al
2010/01/01
Application: Bioassay, Sample Type: In Vivo PubMed
19 Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
Brookes K et al
2010/01/01
Application: Other: See notes, Sample Type: Plasma (EDTA) PubMed
20 Louveau A et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015 Jul;523(7560):337-41
Louveau A et al
2015/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
  • No.: 1
  • 文献情報:
    Al-Mowallad AF et al. Quantification of vascular endothelial growth factor-C. J. Immunol. Methods 2004 Jun;289(1-2):239-40
    Al-Mowallad AF et al
    2004/01/01
  • 備考:
    Application: ELISA Standard
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Liersch R et al. Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood 2006 Feb;107(3):1214-6
    Liersch R et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hamaguchi I et al. Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival. Blood 2006 Feb;107(3):1207-13
    Hamaguchi I et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Shin JW et al. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell 2006 Feb;17(2):576-84
    Shin JW et al
    2006/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
    Le Bras B et al
    2006/01/01
  • 備考:
    Species: Mouse, Xenopus, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zeng Y et al. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res. 2006 Oct;66(19):9566-75
    Zeng Y et al
    2006/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Goldman J et al. Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am. J. Physiol. Heart Circ. Physiol. 2007 May;292(5):H2176-83
    Goldman J et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: In Vivo
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Huber S et al. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int. 2007 Apr;71(8):771-7
    Huber S et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Taniguchi K et al. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol. Cell. Biol. 2007 Jun;27(12):4541-50
    Taniguchi K et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kilic N et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007 Dec;110(13):4223-33
    Kilic N et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Uzarski J et al. The resolution of lymphedema by interstitial flow in the mouse tail skin. Am. J. Physiol. Heart Circ. Physiol. 2008 Mar;294(3):H1326-34
    Uzarski J et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, In Vivo
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Shin JW et al. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood 2008 Sep;112(6):2318-26
    Shin JW et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Kajiya K et al. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J. Invest. Dermatol. 2009 May;129(5):1292-8
    Kajiya K et al
    2009/01/01
  • 備考:
    Application: In Vivo
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Kodama M et al. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin. Cancer Res. 2008 Nov;14(22):7205-14
    Kodama M et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Issa A et al. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res. 2009 Jan;69(1):349-57
    Issa A et al
    2009/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Pan MR et al. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells. J. Cell. Sci. 2009 Sep;122(Pt 18):3358-64
    Pan MR et al
    2009/01/01
  • 備考:
    Application: Media Supplement, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Chien MH et al. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis 2009 Dec;30(12):2005-13
    Chien MH et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Heishi T et al. Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am. J. Pathol. 2010 Apr;176(4):1950-8
    Heishi T et al
    2010/01/01
  • 備考:
    Application: Bioassay, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
    Brookes K et al
    2010/01/01
  • 備考:
    Application: Other: See notes, Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Louveau A et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015 Jul;523(7560):337-41
    Louveau A et al
    2015/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed